Hofseth Biocare ASA

HBC · Oslo Børs · Consumer defensive

1.33NOK +2.3%last day

Price as of 2 October 2026

The price over the past year, with dividends: −24.9%

Performance

1 month

−3.3%

1 year

−24.9%

3 years, per year

−22.0%

5 years, per year

−27.4%

Largest fall, 3 years

−83.2%

Below the peak now

−87.8%

Volatility, 1 year

66.2%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

−22.7

Dividend yield

0.0%

Return on equity

−444.6%

Net margin

−56.4%

Market value

70 m USD

Quality, value and trend

Where Hofseth Biocare stands against every Nordic stock today. 100 is best.

Quality16

Profitability and a sound balance sheet over time. Better than 16% of Nordic stocks.

Value7

The price measured against earnings, assets and cash flow. Better than 7% of Nordic stocks.

Trend24

The price development over the past year. Better than 24% of Nordic stocks.

Combined2

Quality, value and trend together. Better than 2% of Nordic stocks.

About Hofseth Biocare

Hofseth Biocare ASA is a company in consumer defensive, listed on Oslo Børs. The share trades in NOK. It has around 78 employees.

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis